Regan Andrew Insider Trades

Insider Trading History

Track insider trading activity for Regan Andrew. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Conduit Pharmaceuticals- Warrants (22/09/2028)
Conduit Pharmaceuticals- Warrants (22/09/2028) CDTTW
Chief Executive Officer
Holding Value $2.41k 256,393 shares
Last Trade
May 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.15k 100,000 shares
$0.01
$0.01
Conduit Pharmaceuticals
Conduit Pharmaceuticals CDT
Chief Executive Officer
Holding Value $218k 256,393 shares
Last Trade
May 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$212k 100,000 shares
$2.12
$0.85
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War)
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War) MURFU
Chief Executive Officer
Holding Value $4.25M 256,393 shares
Last Trade
May 13, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.66M 100,000 shares
$16.56
$16.56
Conduit Pharmaceuticals
Conduit Pharmaceuticals CDT
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Mar 24, 2026 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$1.82M 147,401 shares
$12.35
$0.85
Conduit Pharmaceuticals- Warrants (22/09/2028)
Conduit Pharmaceuticals- Warrants (22/09/2028) CDTTW
Chief Executive Officer
Holding Value $1.47k 156,393 shares
Last Trade
Mar 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$973 147,401 shares
$0.01
$0.01
Conduit Pharmaceuticals
Conduit Pharmaceuticals CDT
Chief Executive Officer
Holding Value $133k 156,393 shares
Last Trade
Mar 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.82M 147,401 shares
$12.35
$0.85
Conduit Pharmaceuticals- Warrants (22/09/2028)
Conduit Pharmaceuticals- Warrants (22/09/2028) CDTTW
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Mar 24, 2026 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$973 147,401 shares
$0.01
$0.01
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War)
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War) MURFU
Chief Executive Officer
Holding Value $2.59M 156,393 shares
Last Trade
Mar 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.44M 147,401 shares
$16.56
$16.56
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War)
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War) MURFU
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Mar 24, 2026 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$2.44M 147,401 shares
$16.56
$16.56
Conduit Pharmaceuticals- Warrants (22/09/2028)
Conduit Pharmaceuticals- Warrants (22/09/2028) CDTTW
10% owner, Chief Executive Officer
Holding Value $34.6k 3,685,815 shares
Last Trade
Dec 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$40.7k 3,910,615 shares
$0.01
$0.01
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War)
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War) MURFU
10% owner, Chief Executive Officer
Holding Value $61M 3,685,815 shares
Last Trade
Dec 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$64.8M 3,910,615 shares
$16.56
$16.56
Conduit Pharmaceuticals
Conduit Pharmaceuticals CDT
10% owner, Chief Executive Officer
Holding Value $3.13M 3,685,815 shares
Last Trade
Dec 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$193M 3,910,615 shares
$49.25
$0.85
Conduit Pharmaceuticals- Warrants (22/09/2028)
Conduit Pharmaceuticals- Warrants (22/09/2028) CDTTW
10% owner, Chief Executive Officer
Holding Value $10.5k 1,120,044 shares
Last Trade
Sep 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.9k 1,120,000 shares
$0.01
$0.01
Conduit Pharmaceuticals
Conduit Pharmaceuticals CDT
10% owner, Chief Executive Officer
Holding Value $952k 1,120,044 shares
Last Trade
Sep 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.46M 1,120,000 shares
$5.77
$0.85
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War)
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War) MURFU
10% owner, Chief Executive Officer
Holding Value $18.5M 1,120,044 shares
Last Trade
Sep 19, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$18.3M 1,120,000 shares
$16.36
$16.56
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War)
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War) MURFU
10% owner, Chief Executive Officer
Holding Value $2.56M 154,799 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.53M 154,799 shares
$16.36
$16.56
Conduit Pharmaceuticals- Warrants (22/09/2028)
Conduit Pharmaceuticals- Warrants (22/09/2028) CDTTW
10% owner, Chief Executive Officer
Holding Value $1.46k 154,799 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.66k 154,799 shares
$0.01
$0.01
Conduit Pharmaceuticals
Conduit Pharmaceuticals CDT
10% owner, Chief Executive Officer
Holding Value $132k 154,799 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$500k 154,799 shares
$3.23
$0.85
Murphy Canyon Acquisition
Murphy Canyon Acquisition MURF
10% owner, Chief Executive Officer
Holding Value $2.61M 154,799 shares
Last Trade
Jun 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.61M 154,799 shares
$16.85
$16.85
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War)
Murphy Canyon Acquisition - Units (1 Ord Class A & 1 War) MURFU
10% owner
Holding Value $2.94M 177,627 shares
Last Trade
Jul 17, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$24.8M 1,514,100 shares
$16.36
$16.56

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up